A cutoff score of 33.5 on the CSI may be useful for discriminating widespread pain sensitivity and quality of life impairments in participants with CMP. Future studies should consider how the presence of high or low CSI may impact differential diagnosis, prognosis, and treatment responsiveness for patients with primary or secondary CMP.
No takes yet. Share an insight, caveat, or question.
Zafereo et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: